title: Focal or combined modality for the management of brain metastasis: did high tech radiotherapy superseded drug-radiotherapy combination?
authors.affiliation: Department of Radiation Oncology and DITEP, SIRIC Socrates Gustave Roussy Cancer Campus,Villejuif; Université Paris-Sud, DHU TORINO, Paris; INSERM 1030 Molecular Radiotherapy, Villejuif. Electronic address: eric.deutsch@gustaveroussy.fr.
authors.forename: E
authors.initials: E
authors.lastname: Deutsch
authors.affiliation: Department of Radiation Oncology and DITEP, SIRIC Socrates Gustave Roussy Cancer Campus,Villejuif.
authors.forename: F
authors.initials: F
authors.lastname: Dhermain
authors.affiliation: Department of Radiation Oncology and DITEP, SIRIC Socrates Gustave Roussy Cancer Campus,Villejuif; INSERM 1030 Molecular Radiotherapy, Villejuif; Hopital D'instruction des Armées du Val de Grâce, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Chargari
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans
chemical_list: D000970:Antineoplastic Agents